The Food and Drug Administration should move more quickly to ensure pulse oximeters — the ubiquitous devices used to measure blood oxygen — work well
Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history. This week
Since the 1920s, lead vests and aprons have served as trusted shields against the harmful effects of X-rays for radiologists, technicians, and patients. But new
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Edwards Lifesciences received approval from
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Kevin Hykes Permission granted by CVRx Name:
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medical devices patients can use
Alto Neuroscience, Inc. (NYSE: ANRO) recently announced the launch of its significantly expanded initial public offering (IPO), offering 8,040,000 shares of common stock at a
Numinus Wellness Inc. (OTCQX: NUMIF) has successfully orchestrated a financing strategy to secure $6 million by entering into a definitive agreement for a bought deal,
SARASOTA, FL, Feb. 01, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing
VANCOUVER, British Columbia, Feb. 01, 2024 (GLOBE NEWSWIRE) — Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI), a mental health care company advancing traditional